TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE GLOBAL AUTOLOGOUS FAT GRAFTING MARKET 13
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 19
2.1 MARKETS COVERED 19
2.2 GEOGRAPHICAL SCOPE 20
2.3 YEARS CONSIDERED FOR THE STUDY 21
2.4 CURRENCY AND PRICING 21
2.5 DBMR TRIPOD DATA VALIDATION MODEL 22
2.6 MULTIVARIANT MODELLING 25
2.7 PRODUCT TYPE LIFELINE CURVE 25
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.9 DBMR MARKET POSITION GRID 27
2.10 VENDOR SHARE ANALYSIS 28
2.11 MARKET END USER COVERAGE GRID 29
2.12 SECONDARY SOURCES 30
2.13 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 33
4.1 PESTEL ANALYSIS 36
4.2 PORTER’S FIVE FORCES MODEL 37
5 REGULATIONS 38
6 MARKET OVERVIEW 41
6.1 DRIVERS 43
6.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 43
6.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS 44
6.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS 45
6.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES 46
6.2 RESTRAINTS 47
6.2.1 HIGH COST OF PROCEDURES 47
6.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 48
6.3 OPPORTUNITIES 48
6.3.1 BELIEF AND TREND OF AUTOLOGOUS FAT GRAFTING IN YOUNG ADULTS 48
6.3.2 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES 50
6.4 CHALLENGES 51
6.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO 51
6.4.2 LACK OF SKILLED PERSONNEL 51
7 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY PRODUCT TYPE 52
7.1 OVERVIEW 53
7.2 LIPOSUCTION SYSTEMS 54
7.3 ASPIRATION AND HARVESTING SYSTEMS 55
7.4 FAT PROCESSING SYSTEMS 55
7.5 INTEGRATED FAT TRANSFER SYSTEMS 56
7.6 DE-EPITHELIALIZATION DEVICES 56
7.7 ACCESSORIES 57
8 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY APPLICATION 58
8.1 OVERVIEW 59
8.2 BREAST AUGMENTATION 60
8.3 BUTTOCK AUGMENTATION 61
8.4 FACIAL FAT GRAFTING 61
8.5 HAND REJUVENATION 62
8.6 OTHERS 62
9 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY GENDER 63
9.1 OVERVIEW 64
9.2 FEMALE 65
9.3 MALE 66 
10 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY AGE GROUP 67
10.1 OVERVIEW 68
10.2 41-50 69
10.3 20-40 70
10.4 ABOVE 50 70
11 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY END USER 71
11.1 OVERVIEW 72
11.2 HOSPITALS 73
11.3 PLASTIC SURGERY CENTERS 74
11.4 ON-SITE CLINICS 74
11.5 OTHERS 74
12 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY DISTRIBUTION CHANNEL 76
12.1 OVERVIEW 77
12.2 DIRECT TENDER 78
12.3 RETAIL SALES 79
13 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET, BY REGION 80
13.1 OVERVIEW 81
13.2 NORTH AMERICA 83
13.2.1 U.S. 83
13.2.2 CANADA 83
13.2.3 MEXICO 83
13.3 EUROPE 84
13.3.1 GERMANY 84
13.3.2 TURKEY 84
13.3.3 ITALY 84
13.3.4 FRANCE 84
13.3.5 SPAIN 84
13.3.6 RUSSIA 84
13.3.7 U.K. 84
13.3.8 NETHERLANDS 84
13.3.9 SWITZERLAND 84
13.3.10 POLAND 84
13.3.11 SWEDEN 85
13.3.12 BELGIUM 85
13.3.13 DENMARK 85
13.3.14 FINLAND 85
13.3.15 NORWAY 85
13.3.16 REST OF EUROPE 85
13.4 ASIA-PACIFIC 86
13.4.1 CHINA 86
13.4.2 JAPAN 86
13.4.3 INDIA 86
13.4.4 SOUTH KOREA 86
13.4.5 AUSTRALIA 86
13.4.6 SINGAPORE 86
13.4.7 THAILAND 86
13.4.8 INDONESIA 86
13.4.9 PHILIPPINES 86
13.4.10 MALAYSIA 86
13.4.11 NEW ZEALAND 87
13.4.12 VIETNAM 87
13.4.13 TAIWAN 87
13.4.14 REST OF ASIA PACIFIC 87
13.5 SOUTH AMERICA 88
13.5.1 BRAZIL 88
13.5.2 ARGENTINA 88
13.5.3 REST OF SOUTH AMERICA 88
13.6 MIDDLE EAST AND AFRICA 89
13.6.1 SAUDI ARABIA 89
13.6.2 EGYPT 89
13.6.3 U.A.E. 89
13.6.4 SOUTH AFRICA 89
13.6.5 KUWAIT 89
13.6.6 QATAR 89
13.6.7 OMAN 89
13.6.8 BAHRAIN 89
13.6.9 REST OF MIDDLE EAST AND AFRICA 89
14 GLOBAL AUTOLOGOUS FAT GRAFTING MARKET: COMPANY LANDSCAPE 90
14.1 COMPANY SHARE ANALYSIS: GLOBAL 90
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 91
14.3 COMPANY SHARE ANALYSIS: EUROPE 92
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 93 
15 COMPANY PROFILES 94
15.1 ABBVIE INC. 94
15.1.1 COMPANY SNAPSHOT 94
15.1.2 REVENUE ANALYSIS 94
15.1.3 COMPANY SHARE ANALYSIS 95
15.1.4 PRODUCT PORTFOLIO 95
15.1.5 RECENT DEVELOPMENTS 95
15.2 CYNOSURE 96
15.2.1 COMPANY SNAPSHOT 96
15.2.2 COMPANY SHARE ANALYSIS 96
15.2.3 PRODUCT PORTFOLIO 96
15.2.4 RECENT DEVELOPMENT 96
15.3 SOLTA MEDICAL 97
15.3.1 COMPANY SNAPSHOT 97
15.3.2 COMPANY SHARE ANALYSIS 97
15.3.3 PRODUCT PORTFOLIO 97
15.3.4 RECENT DEVELOPMENT 97
15.4 ALMA LASERS 98
15.4.1 COMPANY SNAPSHOT 98
15.4.2 COMPANY SHARE ANALYSIS 98
15.4.3 PRODUCT PORTFOLIO 99
15.4.4 RECENT DEVELOPMENT 99
15.5 MENTOR WORLDWIDE LLC 100
15.5.1 COMPANY SNAPSHOT 100
15.5.2 COMPANY SHARE ANALYSIS 100
15.5.3 PRODUCT PORTFOLIO 100
15.5.4 RECENT DEVELOPMENT 100
15.6 ASPIRE MEDICAL INNOVATION 101
15.6.1 COMPANY SNAPSHOT 101
15.6.2 PRODUCT PORTFOLIO 101
15.6.3 RECENT DEVELOPMENT 101
15.7 BIMINI HEALTH TECH 102
15.7.1 COMPANY SNAPSHOT 102
15.7.2 PRODUCT PORTFOLIO 102
15.7.3 RECENT DEVELOPMENTS 102
15.8 BLACK & BLACK SURGICAL 103
15.8.1 COMPANY SNAPSHOT 103
15.8.2 PRODUCT PORTFOLIO 103
15.8.3 RECENT DEVELOPMENT 103
15.9 GENESIS BIOSYSTEMS 104
15.9.1 COMPANY SNAPSHOT 104
15.9.2 PRODUCT PORTFOLIO 104
15.9.3 RECENT DEVELOPMENT 104
15.10 GREY MEDICAL 105
15.10.1 COMPANY SNAPSHOT 105
15.10.2 PRODUCT PORTFOLIO 105
15.10.3 RECENT DEVELOPMENT 105
15.11 HK SURGICAL INC. 106
15.11.1 COMPANY SNAPSHOT 106
15.11.2 PRODUCT PORTFOLIO 106
15.11.3 RECENT DEVELOPMENT 106
15.12 HUMAN MED AG 107
15.12.1 COMPANY SNAPSHOT 107
15.12.2 PRODUCT PORTFOLIO 107
15.12.3 RECENT DEVELOPMENT 107
15.13 LIPOGEMS INTERNATIONAL S.P.A. 108
15.13.1 COMPANY SNAPSHOT 108
15.13.2 PRODUCT PORTFOLIO 108
15.13.3 RECENT DEVELOPMENT 108
15.14 MEDICON EG 109
15.14.1 COMPANY SNAPSHOT 109
15.14.2 PRODUCT PORTFOLIO 109
15.14.3 RECENT DEVELOPMENT 109
15.15 MICROAIRE SURGICAL INSTRUMENTS, LLC 110
15.15.1 COMPANY SNAPSHOT 110
15.15.2 PRODUCT PORTFOLIO 110
15.15.3 RECENT DEVELOPMENT 110
15.16 MOLLER MEDICAL GMBH 111
15.16.1 COMPANY SNAPSHOT 111
15.16.2 PRODUCT PORTFOLIO 111
15.16.3 RECENT DEVELOPMENT 111
15.17 MTF BIOLOGICS 112
15.17.1 COMPANY SNAPSHOT 112
15.17.2 PRODUCT PORTFOLIO 112
15.17.3 RECENT DEVELOPMENT 112
15.18 STERIMEDIX LIMITED 113
15.18.1 COMPANY SNAPSHOT 113
15.18.2 PRODUCT PORTFOLIO 113
15.18.3 RECENT DEVELOPMENT 113
15.19 TULIP AESTHETICS 114
15.19.1 COMPANY SNAPSHOT 114
15.19.2 PRODUCT PORTFOLIO 114
15.19.3 RECENT DEVELOPMENT 114
16 QUESTIONNAIRE 115
17 RELATED REPORTS 118